{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:59:54Z","timestamp":1790816394273,"version":"4.1.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"19","license":[{"start":{"date-parts":[[2018,6,30]],"date-time":"2018-06-30T00:00:00Z","timestamp":1530316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100007077","name":"National Institute of Biomedical Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-05-MRAR-035"],"award-info":[{"award-number":["ANR-05-MRAR-035"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011103","name":"European Union Sixth Framework Programme","doi-asserted-by":"publisher","award":["018690"],"award-info":[{"award-number":["018690"]}],"id":[{"id":"10.13039\/100011103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10,1]]},"DOI":"10.1093\/hmg\/ddy243","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T23:08:07Z","timestamp":1530227287000},"page":"3353-3360","source":"Crossref","is-referenced-by-count":19,"title":["N-acetyl cysteine alleviates oxidative stress and protects mice from dilated cardiomyopathy caused by mutations in nuclear A-type lamins gene"],"prefix":"10.1093","volume":"27","author":[{"given":"Blanca Morales","family":"Rodriguez","sequence":"first","affiliation":[{"name":"Sorbonne Universit\u00e9, UPMC Paris 06, INSERM UMRS974, Center of Research in Myology, Institut de Myologie, Paris, France"},{"name":"Sanofi R&D, Chilly-Mazarin, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Khouzami","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Est Cr\u00e9teil, Inserm UMRS 955, IMRB, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Decostre","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, UPMC Paris 06, INSERM UMRS974, Center of Research in Myology, Institut de Myologie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaida","family":"Varnous","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, UPMC Paris 06, INSERM UMRS974, Center of Research in Myology, Institut de Myologie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanja","family":"Pekovic-Vaughan","sequence":"additional","affiliation":[{"name":"Institute of Ageing and Chronic Disease, William Henry Duncan Building, University of Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J","family":"Hutchison","sequence":"additional","affiliation":[{"name":"Chancellery Building, Murdoch University, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Pecker","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Est Cr\u00e9teil, Inserm UMRS 955, IMRB, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gis\u00e8le","family":"Bonne","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, UPMC Paris 06, INSERM UMRS974, Center of Research in Myology, Institut de Myologie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Muchir","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, UPMC Paris 06, INSERM UMRS974, Center of Research in Myology, Institut de Myologie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,8,1]]},"reference":[{"key":"key\n\t\t\t\t20180917102158_ref1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/6799","article-title":"Mutations in the gene encoding lamin A\/C cause autosomal dominant Emery\u2013Dreifuss muscular dystrophy","volume":"21","author":"Bonne","year":"1999","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20180917102158_ref2","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJM199912023412302","article-title":"Missense mutations in the rod domain of the lamin A\/C gene as causes of dilated cardiomyopathy and conduction-system disease","volume":"341","author":"Fatkin","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20180917102158_ref3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMc052632","article-title":"Primary prevention of sudden death in patients with lamin A\/C gene mutations","volume":"354","author":"Meune","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20180917102158_ref4","first-page":"848","article-title":"Heart involvement in lamin A\/C related diseases","volume":"99","author":"Ben Yaou","year":"2006","journal-title":"Arch. Mal. Coeur Vaiss."},{"key":"key\n\t\t\t\t20180917102158_ref5","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1242\/dmm.006346","article-title":"LMNA cardiomyopathy: cell biology and genetics meet clinical medicine","volume":"4","author":"Lu","year":"2011","journal-title":"Dis. Model. Mech."},{"key":"key\n\t\t\t\t20180917102158_ref6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/hmg\/ddi017","article-title":"Mouse model carrying H222P-Lmna mutation develops muscular dystrophyand dilated cardiomyopathy similar to human striated muscle laminopathies","volume":"14","author":"Arimura","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20180917102158_ref7","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1172\/JCI29042","article-title":"Activation of MAPK pathway links LMNA mutations to cardiomyopathy in Emery\u2013Dreifuss muscular dystrophy","volume":"117","author":"Muchir","year":"2007","journal-title":"J. Clin. Invest."},{"key":"key\n\t\t\t\t20180917102158_ref8","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1093\/hmg\/dds265","article-title":"Abnormal p38a mitogen activated protein kinase signalling in dilated cardiomyopathy caused by lamin A\/C gene mutation","volume":"21","author":"Muchir","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20180917102158_ref9","first-page":"333","article-title":"Decreased WNT\/b-catenin signalling contributes to the pathogenesis of dilated cardiomyopathy caused by mutations in the lamin A\/C gene","volume":"26","author":"Le Dour","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20180917102158_ref10","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1093\/hmg\/ddw090","article-title":"ERK1\/2 directly acts on CTGF\/CCN2 expression to mediate myocardiacl fibrosis in cardiomyopathy caused by mutation in the lamin A\/C gene","volume":"25","author":"Chatzifrangkeskou","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20180917102158_ref11","doi-asserted-by":"crossref","first-page":"144ra102","DOI":"10.1126\/scitranslmed.3003875","article-title":"Temsirolimus activates autophagy and ameliorates cardiomyopathy caused by lamin A\/C gene mutation","volume":"4","author":"Choi","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"key\n\t\t\t\t20180917102158_ref12","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jacc.2009.10.065","article-title":"Improvement of left ventricular dysfunction and of survival prognosis of dilated cardiomyopathy by administration of calcium sensitizer SCH00013 in a mouse model","volume":"55","author":"Arimura","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"key\n\t\t\t\t20180917102158_ref13","first-page":"37","article-title":"Cell signaling abnormalities in cardiomyopathy caused by lamin A\/C gene mutations","author":"Worman","year":"2018"},{"key":"key\n\t\t\t\t20180917102158_ref14","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.bbrc.2012.04.058","article-title":"Lamins as mediators of oxidative stress","volume":"421","author":"Sieprath","year":"2012","journal-title":"Bioch. Biophys. Res. Comm."},{"key":"key\n\t\t\t\t20180917102158_ref15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cub.2014.03.034","article-title":"ROS function in redox signaling and oxidative stress","volume":"24","author":"Schieber","year":"2014","journal-title":"Curr. Biol."},{"key":"key\n\t\t\t\t20180917102158_ref16","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/1531-8249(200008)48:2<170::AID-ANA6>3.0.CO;2-J","article-title":"Clinical and molecular genetic spectrum of autosomal dominant Emery\u2013Dreifuss muscular dystrophy due to mutations of the lamin A\/C gene","volume":"48","author":"Bonne","year":"2000","journal-title":"Ann. Neurol."},{"key":"key\n\t\t\t\t20180917102158_ref17","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/sj.cdd.4402197","article-title":"Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence","volume":"14","author":"Caron","year":"2007","journal-title":"Cell Death Differ."},{"key":"key\n\t\t\t\t20180917102158_ref18","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/10715760601110046","article-title":"Oxidative stress implication in a new phenotype of amyotrophic quadricipital syndrome with cardiac involvement due to lamin A\/C mutation","volume":"41","author":"Charniot","year":"2007","journal-title":"Free Radic. Res."},{"key":"key\n\t\t\t\t20180917102158_ref19","doi-asserted-by":"crossref","first-page":"H2181","DOI":"10.1152\/ajpheart.00554.2011","article-title":"Oxidative stress and heart failure","volume":"301","author":"Tsutsui","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"key\n\t\t\t\t20180917102158_ref20","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0891-5849(01)00724-9","article-title":"Reactive oxygen species, antioxidants, and the mammalian thioredoxin system","volume":"31","author":"Nordberg","year":"2001","journal-title":"Free Radic. Biol. Med."},{"key":"key\n\t\t\t\t20180917102158_ref21","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jacc.2005.10.041","article-title":"Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation","volume":"47","author":"Marian","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"key\n\t\t\t\t20180917102158_ref22","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1253\/circj.70.1001","article-title":"Elevated levels of oxidative DNA damage in serum and myocardium of patients with heart failure","volume":"70","author":"Kono","year":"2006","journal-title":"Circ. J."},{"key":"key\n\t\t\t\t20180917102158_ref23","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s12265-013-9462-3","article-title":"New and emerging biomarkers in left ventricular systolic dysfunction-insight into dilated cardiomyopathy","volume":"6","author":"Gopal","year":"2013","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"key\n\t\t\t\t20180917102158_ref24","doi-asserted-by":"crossref","first-page":"E966","DOI":"10.3390\/nu9090966","article-title":"Antioxidant therapeutic strategies for cardiovascular conditions associated with oxidative stress","volume":"9","author":"Far\u00edas","year":"2017","journal-title":"Nutrients"},{"key":"key\n\t\t\t\t20180917102158_ref25","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/hmg\/ddr327","article-title":"The accumulation of un-repairable DNA damage in laminopathy progeria fibroblasts is caused by ROS generation and is prevented by treatment with N-acetyl cysteine","volume":"20","author":"Richards","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20180917102158_ref26","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1474-9726.2011.00750.x","article-title":"Conserved cysteine residues in the mammalian lamin A tail are essential for cellular responses to ROS generation","volume":"10","author":"Pekovic","year":"2011","journal-title":"Aging Cell"},{"key":"key\n\t\t\t\t20180917102158_ref27","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1128\/MCB.01676-12","article-title":"Lamin A\/C depletion enhances DNA damage-induced stalled replication fork arrest","volume":"33","author":"Singh","year":"2013","journal-title":"Mol. Cell Biol."},{"key":"key\n\t\t\t\t20180917102158_ref28","first-page":"245","article-title":"Pharmacokinetic and pharmacodynamic studies of N-acetylcysteine, a potential chemopreventive agent during a phase I trial","volume":"4","author":"Pendyala","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"key\n\t\t\t\t20180917102158_ref29","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0003-2697(69)90064-5","article-title":"Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues","volume":"27","author":"Tietze","year":"1969","journal-title":"Anal. Biochem."},{"key":"key\n\t\t\t\t20180917102158_ref30","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.yjmcc.2007.06.010","article-title":"Neutral sphingomyelinase inhibition participates to the benefits of N-acetylcysteine treatment in post-myocardial infarction failing heart rats","volume":"43","author":"Adamy","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"key":"key\n\t\t\t\t20180917102158_ref31","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1038\/nprot.2006.378","article-title":"Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method","volume":"1","author":"Rahman","year":"2006","journal-title":"Nat. Protoc."},{"key":"key\n\t\t\t\t20180917102158_ref32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1472-6750-3-18","article-title":"Real-time PCR based on SYBR-Green I fluorescence: an alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletions","volume":"3","author":"Ponchel","year":"2003","journal-title":"BMC Biotechnol."}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/27\/19\/3353\/25741199\/ddy243.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T00:24:45Z","timestamp":1571531085000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article\/27\/19\/3353\/5046717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,1]]},"references-count":32,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2018,8,1]]},"published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddy243","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"value":"0964-6906","type":"print"},{"value":"1460-2083","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,10,1]]},"published":{"date-parts":[[2018,8,1]]}}}